Doctor profile · Federal record
Dr. Jessica Runquist, PA-C
Physician Assistant · Physician Assistant · Swansea, MA
- NPI 1124557376
- 9 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1675 Gar Hwy
Swansea, MA 027773901
(508) 490-5959
fax (508) 490-5960 - Additional location
-
1287 N Main St
Providence, RI 029041856
(401) 272-2724
fax (401) 272-2784
Credentials & registration
- NPI registered
- June 2017 — 9 yrs on file
- Profile last updated
- December 13, 2019
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State licenses (2)
- Massachusetts #PA6233 · Rhode Island #PA01115
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1124557376. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,603
Distinct HCPCS
10
Medicare allowed
$94,968
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 478 | 359 | $79 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 387 | 90 | $6 | |
17000 |
Destruction of precancer skin growth, 1 growth | 177 | 139 | $49 | |
11102 |
Biopsy of related skin growth, first growth | 162 | 146 | $85 | |
17110 |
Destruction of skin growth, 1-14 growths | 120 | 102 | $102 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 86 | 81 | $49 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 79 | 79 | $98 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 48 | 34 | $109 | |
11103 |
Biopsy of related skin growth, each additional growth | 46 | 37 | $43 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 20 | 20 | $64 |
In context: peer comparison
Among 2 peers in Swansea Physician Assistant, average services per provider: 135. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$1,278
Transactions
55
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $321.08 | |
| Janssen Biotech, INC. | 10 | $290.77 | |
| Abbvie INC. | 17 | $255.70 | |
| Ucb, INC. | 3 | $103.97 | |
| Incyte Corporation | 4 | $82.11 | |
| Pfizer INC. | 3 | $48.60 | |
| Novartis Pharmaceuticals Corporation | 2 | $48.49 | |
| Genzyme Corporation | 2 | $33.32 | |
| Biofrontera INC. | 1 | $26.83 | |
| Dermavant Sciences, INC. | 1 | $24.88 | |
| Galderma Laboratories, L.P. | 1 | $21.56 | |
| Amgen INC. | 1 | $20.62 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
501
Patients
278
Total drug cost
$652,940
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 120 | 64 | $2,227 |
| Triamcinolone Acetonide | Generic | 98 | 77 | $1,091 |
| Fluorouracil | Generic | 48 | 43 | $4,190 |
| Clobetasol Propionate | Generic | 43 | 24 | $3,318 |
| Doxycycline Hyclate | Generic | 32 | 13 | $1,426 |
| Hydrocortisone | Generic | 22 | 19 | $107 |
| Tacrolimus | Generic | 19 | 13 | $5,711 |
| Clindamycin Phosphate | Generic | 18 | 0 | $656 |
| Mometasone Furoate | Generic | 17 | 14 | $281 |
| Skyrizi (Risankizumab-Rzaa) | Brand | 17 | 0 | $355,283 |
Frequently asked questions
What is Dr. Jessica Runquist's medical specialty?
Dr. Jessica Runquist practices Physician Assistant in Swansea, MA.
Where does Dr. Jessica Runquist practice?
Dr. Jessica Runquist practices at 1675 Gar Hwy, Swansea, MA 027773901. Office phone: 5084905959.
What is Dr. Jessica Runquist's NPI?
Dr. Jessica Runquist's National Provider Identifier (NPI) is 1124557376, issued by NPPES.
Does Dr. Jessica Runquist accept Medicare assignment?
Dr. Jessica Runquist does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Jessica Runquist commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.